Application of transcranial brain stimulation in dementia

Keyphrases

• Dementia 100%
• Alzheimer's Disease 100%
• Deep Brain Stimulation 66%
• Transcranial Magnetic Stimulation 66%
• Patients with Dementia 66%
• Transcranial Direct-current Stimulation (tDCS) 66%
• Transcranial Ultrasound Stimulation 66%
• Cognitive Function 33%
• Clinical Trials 33%
• Electrical Stimulation 33%
• Physical Properties 33%
• World Population 33%
• Thermal Energy 33%
• Focused Ultrasound 33%
• Neural Activity 33%
• Population Aging 33%
• Caregiver Burden 33%
• Neuromodulation 33%
• Mechanical Energy 33%
• Medical Devices 33%
• Number of Patients 33%
• Brain Stimulation 33%
• Amyloid Protein 33%
• Alternative Therapeutics 33%
• Low-intensity Pulsed Ultrasound (LIPUS) 33%
• Clinical Effect 33%
• Blood-brain Barrier Opening 33%
• Neuroprotective Effect 33%
• Acetylcholinesterase Inhibitors (AChEI) 33%
• N-methyl-D-aspartate Receptor Antagonist 33%
• Invasive Surgery 33%
• Ongoing Clinical Trials 33%

Medicine and Dentistry

• Electrical Brain Stimulation 100%
• Clinical Trial 66%
• Alzheimer's Disease 66%
• Transcranial Direct Current Stimulation 66%
• Transcranial Magnetic Stimulation 66%
• Deep Brain Stimulation 66%
• Health Care 33%
• In Vitro 33%
• Blood Brain Barrier 33%
• Medical Device 33%
• Neuromodulation 33%
• Neuroprotective Agent 33%
• Patient with Alzheimer's Disease 33%
• Low-Intensity Pulsed Ultrasound 33%
• Acetylcholinesterase Inhibitor 33%
• Amyloid Protein 33%
• Electrotherapy 33%
• NMDA Receptor Antagonist 33%
• Cognition 33%

Neuroscience

• Electrical Brain Stimulation 100%
• Alzheimer's Disease 100%
• Transcranial Direct Current Stimulation 66%
• Transcranial Magnetic Stimulation 66%
• Deep Brain Stimulation 66%
• Cognitive Function 33%
• In Vivo 33%
• In Vitro 33%
• Blood Brain Barrier 33%
• Neuromodulation 33%
• Neuroprotective Agent 33%
• Acetylcholinesterase Inhibitor 33%
• NMDA Receptor Antagonist 33%
• Amyloid Protein 33%
• Electrotherapy 33%